FDA Clearance Tracker · K170118
Scanostics UTI Check Application Test System
Last checked: Nov 20, 2026Latest source record: Sep 21, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Sep 21, 2017
Substantially Equivalent
Time to decision
251 days
Received Jan 13, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K170118
- Device name
- Scanostics UTI Check Application Test System
- Applicant
- Teco Diagnostics
- Applicant location
- Anaheim, CA
- Received
- Jan 13, 2017
- Decided
- Sep 21, 2017
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 862.1510
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JMT. The earliest in FDA's data is K840828, decided May 14, 1984.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K170118
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Teco Diagnostics
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K161527 · Decided Jul 21, 2017 · 414 days after receipt
Device type: Enzymatic Method, Creatinine (JFY) · Laboratory Medicine & Pathology
K170200 · Decided Jun 1, 2017 · 129 days after receipt
Device type: Enzymatic, Carbon-Dioxide (KHS) · Laboratory Medicine & Pathology
K160372 · Decided Jul 22, 2016 · 163 days after receipt
Device type: Method, Enzymatic, Glucose (Urinary, Non-Quantitative) (JIL) · Laboratory Medicine & Pathology
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.